Braskem S.A.

NYSE:BAK

Chemicals

Basic Materials
$0.86 -11.76%

-$0.40 today

Market cap
$343.37M
Beta
0.67
P/E (TTM)
-0.7
EPS (TTM)
-$11.45
52W Low $2.32High $5.40

Volume 3.32M

Average 2.97M

BAK Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

Braskem S.A.NYSE: BAK

Short-term Investments · Q1 FY2026 · quarter ended Mar 2026

Short-term investments falls 21.1% from a year ago

Short-term investments stood at R$1.35B at the end of Q1 FY2026, down 21.1% from a year earlier and up 1.2% from the prior quarter. Over 3 fiscal years it compounded at -16.5% a year.

Context

  • Short-term investments amounted to 1.8% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Short-term investments increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether short-term investments keeps falling in the next quarterly balance sheet after a -21.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
R$1.35B+1.2% QoQ
Last fiscal yearDec 2025
R$1.34B-25.2% YoY
Year agoMar 2025
R$1.71B-21.1% since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-21.1%——
1 year-25.2%——
3-year CAGR-16.5%——
5-year CAGR——
10-year CAGR——

Short-term Investments history

BRL · from the balance sheet

Latest · FY2025
1.34B BRL
Year-over-year change
-25.2%
4-year CAGR
-21.4%

Short-term Investments vs competitors

How BAK compares with its peers on the latest reported figures

  • Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -21.1% is the lowest of 3, against a peer median of +48.9%.
  • Short-term investments amounts to 1.8% of total assets for BAK, versus a peer median of 0.0%.
BAK Competitors
Short-term Investments for BAK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BAKBraskem S.A.Mar 2026R$1.35B BRL-21.1%-16.5%1.8%
REXREX American Resources CorporationApr 2026$246.64M USD+58.1%-4.0%30.5%
ASPIASP Isotopes Inc. Common StockMar 2026$83.17M USD——14.2%
MUXMcEwen Mining Inc.Mar 2026$13.54M USD+39.6%+165.1%1.4%
SCLStepan CompanyMar 2026$0 USD——0.0%
ECVTEcovyst Inc.Mar 2026$0 USD——0.0%
UANCVR Partners, LPMar 2026$0 USD——0.0%
CNLCollective Mining Ltd.Mar 2026$0 USD——0.0%
WLKPWestlake Chemical Partners LPMar 2026$0 USD——0.0%
RYAMRayonier Advanced Materials Inc.Mar 2026$0 USD——0.0%
NAKNorthern Dynasty Minerals Ltd.Mar 2026CA$0 CAD——0.0%
Peer median (excluding BAK) —+48.9%+80.6%0.0%

Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents8.68B12.47B14.19B14.99B10.5B
Short-term Investments3.49B2.3B4.96B1.79B1.34B
Net Receivables10.75B5.51B5.63B6.5B8.19B
Inventory16.27B13.91B12.38B13.47B10.42B
Other Current Assets33.82M158M137M73M0
Total Current Assets39.29B34.46B37.44B37.04B30.43B
Property, Plant & Equipment (Net)40.01B41.72B42.23B44.14B41.44B
Goodwill2.06B2.09B2.17B2.18B1.94B
Intangible Assets818.43M935M935M1.21B1.12B
Long-term Investments75.77M149M165M438M994.5M
Tax Assets8.26B6.36B6.44B13.88B1.56B
Other Non-current Assets2.06B2.35B2.36B2.7B4.35B
Total Non-current Assets53.27B53.59B54.3B64.54B51.41B
Total Assets92.56B88.05B91.74B101.58B81.84B
Account Payables12.05B12.25B13.22B16.88B13.17B
Short-term Debt1.49B2.25B2.77B3.14B21.66B
Tax Payables2.68B872M398M868M0
Deferred Revenue204.67M0000
Other Current Liabilities5.25B5.37B4.1B3.27B4.55B
Total Current Liabilities25.19B24.19B24.49B28.27B40.2B
Long-term Debt49.56B47.33B53.21B66.28B46.37B
Deferred Tax Liabilities2.12B1.89B2.35B1.69B1.47B
Deferred Revenue (Non-current)257.86M0000
Other Non-current Liabilities6.74B5.33B5.45B6.3B7.05B
Total Non-current Liabilities61.17B57.76B63.97B77.58B58.13B
Total Liabilities86.36B81.94B88.46B105.85B98.33B
Common Stock8.04B8.04B8.04B8.04B8.04B
Retained Earnings536.76M253.27M(2.74B)(14.03B)(24.38B)
Accumulated OCI317.25M(244M)(852M)1.7B199.9M
Other Stockholders Equity31.93M39M37M00
Minority Interest(1.66B)(1.21B)(713M)504M(354.82M)
Total Equity6.2B6.11B3.28B(4.28B)(16.49B)
Total Debt54.21B53.83B59.91B73.72B71.28B
Net Debt45.53B41.36B45.72B58.74B60.78B

Braskem S.A.

NYSE:BAK

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.